The docetaxel (DOC) and gemcitabine (GEM) combination as adjuvant chemotherapy in patients with non-small cell lung cancer (NSCLC): A multi-institutional phase II trial

Terumoto Koike(Keio University), Keisuke Eguchi(Keio University), Keigo Kobayashi(Osaka Gakuin University), Yuichi Izumi(Shanghai Institute for Science of Science), Hirozo Sakaguchi(Keio University)
Journal of Clinical Oncology
June 20, 2006
Cited by 0


Related Papers